Peninsula Laboratories品牌介绍

浏览量：1911

Peninsula Laboratories

品牌简介

BMA是BMA Biomedical的缩写，是一家小型生物技术公司，位于瑞士北部巴塞尔地区。1989年由一群免疫学家、生物化学家和生物学家创立，其主要活动领域是抗体的开发、生产和销售。2005年，BMA被Chemoforma Inc.收购。Chemoforma Inc.是一家长期从事免疫支持性饲料添加剂生产的商业合作伙伴。2013年，Chemoforma Inc.收购了总部位于加利福尼亚州的半岛实验室国际公司，该公司专门从事抗肽抗体和放射免疫分析。
BMA的主要专长在于抗体在免疫组织化学和酶免疫分析（ELISA）中的应用。生产完全适应无胎牛血清的培养基。这不仅是对可持续性和动物福利的重要贡献，而且产品不含污染性牛抗体。它们通常仅用于体外研究，但支持向诊断领域的公司发放适当产品的许可证。
BMA拥有自己的设施，拥有最先进的分析和生产基础设施。我们的技术诀窍在于单克隆抗体和多克隆抗体的生产和衍生，以及它们在免疫学技术中的应用。BMA还许可来自外部组织的产品。这些可能处于早期开发阶段，最终由公司进行更新以供制造。

BMA, short for BMA Biomedicals, is a small biotech company located in the Basel area in northern Switzerland. Founded in 1989 by a group of immunologists, biochemists and biologists, its main area of activity is in the development, production and marketing of antibodies. In 2005, BMA was acquired by Chemoforma Inc., a long-time business partner active in the production of immune-supportive feed additives. In 2013, Chemoforma Inc. acquired Peninsula Laboratories International, Inc., a California-based company specialized in anti-peptide antibodies and radioimmunoassays.

BMA's main expertise lies in the application of antibodies in immunohistochemistry and enzyme immunoassays (ELISAs). Production has fully been adapted to culture media without fetal calf serum. This is not only an important contribution to sustainability and animal welfare, but the products contain no contaminating bovine antibodies. They are generally offered for in vitro research use only, but the licensing of appropriate products to companies in the diagnostics field is supported.

BMA operates its own facilities with state-of-the-art analytical and production infrastructure. Our know-how lies in the production and derivatisation of monoclonal and polyclonal antibodies, and their use in immunological techniques. BMA also licenses products from outside organizations. These may be in early development stages and are finally updated for manufacture by the company.

Main product